SEARCH

SEARCH BY CITATION

References

  • ALHENC-GELAS, F., TSAI, S.J., CALLAHAN, K.S., CAMPBELL, W.B. & JOHNSON, A.R. (1982). Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. Prostaglandins, 24, 723742.
  • BRUNELLESCHI, S., TARLI, S., GIOTTI, A. & FANTOZZI, R. (1991). Priming effects of mammalian tachykinins on human neutrophils. Life Sci., 48, PL1PL5.
  • CAUGHEY, G.E., CLELAND, L.G., PENGLIS, P.S., GAMBLE, J.R. & JAMES, M.J. (2001). Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells selective up-regulation of prostacyclin synthesis by COX-2. J. Immunol., 167, 28312838.
  • DAVIES, S.P., REDDY, H., CAIVANO, M. & COHEN, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351, 95105.
  • DIANZANI, C., LOMBARDI, G., COLLINO, M., FERRARA, C., CASSONE, M.C. & FANTOZZI, R. (2001). Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. J. Leukoc. Biol., 69, 10131018.
  • DIANZANI, C., COLLINO, M., LOMBARDI, G., GARBARINO, G. & FANTOZZI, R. (2003). Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br. J. Pharmacol., 139, 11031110.
  • DROUIN, J., SUN, Y.L., CHAMBERLAND, M., GAUTHIER, Y., DE LEAN, A., NEMER, M. & SCHMIDT, T.J. (1993). Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J., 12, 145156.
  • ELIGINI, S., HABIB, A., LEBRET, M., CREMINON, C., LEVY-TOLEDANO, S. & MACLOUF, J. (2001). Induction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production. Br. J. Pharmacol., 133, 11631171.
  • FIEBICH, B.L., SCHLEICHER, S., BUTCHER, R.D., CRAIG, A. & LIEB, K. (2000). The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J. Immunol., 165, 56065611.
  • FOREMAN, J.C. & JORDAN, C.C. (1984). Neurogenic inflammation. Trends Pharmacol. Sci., 5, 116119.
  • GUAN, Z., BUCKMAN, S.Y., MILLER, B.W., SPRINGER, L.D. & MORRISON, A.R. (1998). Interleukin-1beta-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J. Biol. Chem., 273, 2867028676.
  • HARRISON, S. & GEPPETTI, P. (2001). Substance P. Int. J. Biochem. Cell. Biol., 33, 555576.
  • HIRAI, K., EZUMI, Y., NISHIDA, E., UCHIYAMA, T. & TAKAYAMA, H 1999. Comparative study of vanadate- and phorbol ester-induced cyclo-oxygenase-2 expression in human endothelial cells. Thromb. Haemost., 82, 15451552.
  • JAFFE, E.A., NACHMAN, R.L., BECKER, C.G. & MINICK, C.R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52, 27452756.
  • JALLAT-DALOZ, I., COGNARD, J.L., BADET, J.M. & REGNARE, J. (2001). Neural-epithelial cell interplay: in vitro evidence that vagal mediators increase PGE2 production by human nasal epithelial cells. Allergy Asthma Proc., 22, 1723.
  • JOOS, G.F. & PAUWELS, R.A. (2000). Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases Trends Pharmacol. Sci., 21, 131133.
  • KONIG, H., PONTA, H., RAHMSDORF, H.J. & HERRLICH, P. (1992). Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J., 11, 22412246.
  • KOON, H.W., ZHAO, D., NA, X., MOYER, M.P. & POTHOULAKIS, C. (2004). Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J. Biol. Chem., 279, 4551945527.
  • KOYAMA, Y., MIZOBATA, T., YAMAMOTO, N., HASHIMOTO, H., MATSUDA, T. & BABA, A. (1999). Endothelins stimulate expression of cyclooxygenase 2 in rat cultured astrocytes. J. Neurochem., 73, 10041011.
  • KYRIAKIS, J.M. & AVRUCH, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev., 81, 807869.
  • MARCEAU, F., TREMBAY, B., COUTURE, R. & REGOLI, D. (1989). Prostacyclin release induced by neurokinins in cultured human endothelial cells. Can. J. Physiol. Pharmacol., 67, 159162.
  • MARRIOTT, D.R., WILKIN, G.P. & WOOD, J.N. (1991). Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. J. Neurochem., 56, 259265.
  • NEWTON, R., SEYBOLD, J., KUITERT, L.M., BERGMANN, M. & BARNES, P.J. (1998). Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. Biol. Chem., 273, 3231232321.
  • PAGE, N.M. & BELL, N.J. (2002). The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal. Eur. J. Pharmacol., 437, 2730.
  • PATACCHINI, R. & MAGGI, C.A. (1995). Tachykinin receptors and receptor subtypes. Arch. Int. Pharmacodyn. Ther., 329, 161184.
  • PATAK, E., CANDENAS, M.L., PENNEFATHER, J.N., ZICCONE, S., LILLEV, A., MARTIN, J.D., FLORES, C., MANTECON, A.G., STORY, M.E. & PINTO, F.M. (2003). Tachykinins and tachykinin receptors in human uterus. Br. J. Pharmacol., 139, 523532.
  • QUINLAN, K.L., NAIK, S.M., CANNON, G., ARMSTRONG, C.A., BUNNETT, N.W., ANSEL, J.C. & CAUGHMAN, S.W. (1999). Substance P activates coincident NF-AT- and NF-kappa B dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J. Immunol., 163, 56565665.
  • REGOLI, D., BOUDON, A. & FAUCHERE, J.L. (1994). Receptors and antagonists for substance P and related peptides. Pharmacol. Rev., 46, 551599.
  • RIENDEAU, D., PERCIVAL, M.D., BOYCE, S., BRIDEAU, C., CHARLESON, S., CROMLISH, W., ETHIER, D., EVANS, J., FALGUEYRET, J.P., FORD-HUTCHINSON, A.W., GORDON, R., GREIG, G., GRESSER, M., GUAY, J., KARGMAN, S., LEGER, S., MANCINI, J.A., O’NEILL, G., OUELLET, M., RODGER, I.W., THERIEN, M., WANG, Z., WEBB, J.K., WONG, E., XU, L., YOUNG, R.N., ZAMBONI, R., PRASIT, P. & CHAN, C.C. (1997). Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol., 121, 105117.
  • ROZEN, S. & SKALETSKY, H.J. (2000). Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology. eds. Krawetz, S. & Misener, S. pp. 365386. Totowa NJ: Humana Press.
  • SEEGERS, H.C., HOOD, V.C., KIDD, B.L., CRUWYS, S.C. & WALSH, D.A. (2003). Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation. J. Pharmacol. Exp. Ther., 306, 812.
  • TOKUDA, M., MIYAMOTO, R., NAGAOKA, S. & TORII, M. (2004). Substance P enhances expression of lipopolysaccharide-induced inflammatory factors in dental pulp cells. J. Endod., 30, 770773.
  • URACZ, W., URACZ, D., OLSZANECKI, R. & GRYGLEWSKI, R.J. (2002). Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. Physiol. Pharmacol., 53, 643654.
  • VANE, J.R., BAKHLE, Y.S. & BOTTING, R.M. (1998). Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97120.
  • VISHWANATH, R. & MUKHERJEE, R. (1996). Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. Neuroimmunol., 71, 163171.
  • YANG, C.M., HSIAO, L.D., CHIEN, C.S., LIN, C.C., LUO, S.F. & WANG, C.C. (2002). Substance P-induced activation of p42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells. Cell Signal., 14, 913923.
  • ZICHE, M., MORBIDELLI, L., MASINI, E., AMERINI, S., GRANGER, H.J., MAGGI, C.A., GEPPETTI, P. & LEDDA, F. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest., 94, 20362044.